Study on the safety and efficacy of anticolinergics for children with overactive bladder

Study on the safety and efficacy of anticolinergics for children with overactive bladder - Study on the safety and efficacy of anticholinergics for pediatric overactive bladder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017267

Enrollment

150

Registered

2015-04-24

Start date

2012-04-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric overactive bladder

Interventions

Solifenacin 2.5-5mg once daily Propiverine 10-20mg once daily

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diurnal urinary incontinence episode once or more for one week, and diurnal urinary incontinence score one or gerater and sum score of diurnal urinary incontinence, holdng posture and urgency urinary incontinence 3 or greater on dysfunctional voiding scoring system

Exclusion criteria

Exclusion criteria: Voiding dysfunction, Constipation, Postvoid residual urine 50ml or greater, Bladder outlet obstruction, Congenital lower urinary tract anomaly, Polyuria

Design outcomes

Primary

Measure	Time frame
The number of days with diurnal urinary incontinence for one week just before visit to clinics	—

Secondary

Measure	Time frame
Overactive bladder symptom score (OABSS), Dysfunctional voiding scoring system, Postvoid residual urine, Intelligence test	—

Countries

Japan

Contacts

Public ContactHidehiro Kakizaki

Asahikawa Medical University Hospital Department of Renal and Urologic Surgery

kaki@asahikawa-med.ac.jp0166-68-2533

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026